SCHEMBL14767659

SCHEMBL14767659

CC(C)=CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CCc1ccoc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.56
EPAS1 Q99814 1/20 0.56
PTPN2 P17706 3/20 0.48
PTPN1 P18031 3/20 0.48
DUSP3 P51452 3/20 0.48
PTPRC P08575 1/20 0.48
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
KMT2A Q03164 2/20 0.41
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
TRPV1 Q8NER1 1/20 0.38
MAPT P10636 2/20 0.38
ALOX15 P16050 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MEN1 O00255 1/20 0.38
CYP3A4 P08684 1/20 0.38
UGT1A1 P22309 1/20 0.38
USP7 Q93009 1/20 0.37
SQLE Q14534 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14767630 1.00 HIF1A (0.56) HIF1AEPAS1PTPN2PTPN1DUSP3
SCHEMBL31508572 0.93 HIF1A (0.59) HIF1AEPAS1PTPN2PTPN1DUSP3
SCHEMBL11886113 0.93 HIF1A (0.59) HIF1AEPAS1PTPN2PTPN1DUSP3
SCHEMBL14767652 0.93 HIF1A (0.59) HIF1AEPAS1PTPN2PTPN1DUSP3
SCHEMBL14767648 0.89 HIF1A (0.56) HIF1AEPAS1PTPN2PTPN1DUSP3
SCHEMBL14767567 0.89 HIF1A (0.56) HIF1AEPAS1PTPN2PTPN1DUSP3
SCHEMBL14767649 0.87 HIF1A (0.55) HIF1AEPAS1PTPN2PTPN1DUSP3
SCHEMBL14767570 0.87 HIF1A (0.55) HIF1AEPAS1PTPN2PTPN1DUSP3
SCHEMBL14767525 0.87 HIF1A (0.58) HIF1AEPAS1PTPN2PTPN1DUSP3
SCHEMBL17849951 0.85 HIF1A (0.58) HIF1AEPAS1PTPN2PTPN1DUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371301-B2 Prenylarene compound and use thereof OSAKA UNIVERSITY (JP) 2016-06-21 US disclosed
US-9371301-B2 Prenylarene compound and use thereof OSAKA UNIVERSITY (JP) 2016-06-21 US disclosed
US-20130065937-A1 NOVEL PRENYLARENE COMPOUND AND USE THEREOF OSAKA UNIVERSITY (JP) 2013-03-14 US disclosed
US-20130065937-A1 NOVEL PRENYLARENE COMPOUND AND USE THEREOF OSAKA UNIVERSITY (JP) 2013-03-14 US disclosed
EP-2567956-A1 NOVEL PRENYLARENE COMPOUND AND USE THEREOF Osaka University (JP) 2013-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130065937-A1 NOVEL PRENYLARENE COMPOUND AND USE THEREOF H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, NR1H3, HIF1AN HIF1A 12/4885EPAS1 602/4885PTPN2 4565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.